These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19570513)

  • 1. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia.
    Schindler JW; Van Buren D; Foudi A; Krejci O; Qin J; Orkin SH; Hock H
    Cell Stem Cell; 2009 Jul; 5(1):43-53. PubMed ID: 19570513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
    Tsuzuki S; Seto M; Greaves M; Enver T
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.
    de Laurentiis A; Hiscott J; Alcalay M
    Oncogene; 2015 Dec; 34(49):6018-28. PubMed ID: 25893288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEL me all.
    Sloma I; Eaves CJ
    Cell Stem Cell; 2009 Jul; 5(1):5-6. PubMed ID: 19570506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice.
    Tsuzuki S; Seto M
    Stem Cells; 2013 Feb; 31(2):236-47. PubMed ID: 23135987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
    Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C
    Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.
    Sabaawy HE; Azuma M; Embree LJ; Tsai HJ; Starost MF; Hickstein DD
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15166-71. PubMed ID: 17015828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity.
    Morrow M; Horton S; Kioussis D; Brady HJ; Williams O
    Blood; 2004 May; 103(10):3890-6. PubMed ID: 14726384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.
    Ford AM; Palmi C; Bueno C; Hong D; Cardus P; Knight D; Cazzaniga G; Enver T; Greaves M
    J Clin Invest; 2009 Apr; 119(4):826-36. PubMed ID: 19287094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
    Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood leukemia genetic bottleneck phenomenon related to TEL-AML1: the postulation by a mathematical model.
    Ivanovski P; Ivanovski I; Nikolić D; Jovanović I
    Chin Med J (Engl); 2012 Mar; 125(6):1182-5. PubMed ID: 22613552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia.
    Jin W; Wu K; Li YZ; Yang WT; Zou B; Zhang F; Zhang J; Wang KK
    Oncogene; 2013 Apr; 32(15):1978-87. PubMed ID: 22641217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEL/AML1 and immunoreceptor gene rearrangements-which comes first?
    Zuna J; Krejci O; Madzo J; Fronkova E; Sramkova L; Hrusak O; Kalina T; Vaskova M; Stary J; Trka J;
    Leuk Res; 2005 Jun; 29(6):633-9. PubMed ID: 15863202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
    Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
    Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
    Wang XW; Xu YH
    Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL.
    Morrow M; Samanta A; Kioussis D; Brady HJ; Williams O
    Oncogene; 2007 Jun; 26(30):4404-14. PubMed ID: 17237815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
    Tiensiwakul P
    Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.